An Open Label Randomised Trial of RNActive® Cancer Vaccine in High Risk and Intermediate Risk Patients With Prostate Cancer
Clinical trial NCT02140138 · TERMINATED
Trial details
- NCT number
- NCT02140138
- Sponsor
- CureVac
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-06-01
- Primary completion
- 2016-04-01
- Enrollment
- 35
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.